Accentia Biopharmace (ABPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,734 | -9,188 | -5,622 | -7,962 | 661 |
| Depreciation Amortization | 44 | 250 | 205 | 164 | 129 |
| Accounts receivable | 20 | 863 | 680 | 611 | -208 |
| Accounts payable and accrued liabilities | 142 | 466 | 216 | 383 | 270 |
| Other Working Capital | 2,125 | 6,671 | 4,730 | 3,262 | 1,572 |
| Other Operating Activity | 5,019 | 316 | -4,957 | 751 | -3,771 |
| Operating Cash Flow | $-1,384 | $-622 | $-4,748 | $-2,791 | $-1,347 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -98 | -318 | -122 | -98 |
| Other Investing Activity | 0 | 5,500 | 5,500 | 5,500 | 4,000 |
| Investing Cash Flow | $-5 | $5,402 | $5,182 | $5,378 | $3,903 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,710 | 3,500 | 2,500 | 2,000 | 1,000 |
| Common Stock Issued | N/A | 805 | 805 | 545 | N/A |
| Other Financing Activity | 3 | -3,689 | -3,682 | -3,671 | -3,679 |
| Financing Cash Flow | $1,713 | $616 | $-377 | $-1,126 | $-2,679 |
| Beginning Cash Position | 129 | 421 | 421 | 421 | 421 |
| End Cash Position | 454 | 129 | 477 | 1,881 | 297 |
| Net Cash Flow | $324 | $-291 | $57 | $1,461 | $-124 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,384 | -622 | -4,748 | -2,791 | -1,347 |
| Capital Expenditure | -5 | -98 | -318 | -122 | -98 |
| Free Cash Flow | -1,388 | -720 | -5,067 | -2,913 | -1,445 |